ETF Daily News logo

The Latest Headlines at ETF Daily News

Image about Compass Point Increases Ambac Financial Group (NYSE:AMBC) Price Target to $19.00

Compass Point Increases Ambac Financial Group (NYSE:AMBC) Price Target to $19.00

Ambac Financial Group (NYSE:AMBC – Get Free Report) had its price objective raised by equities research analysts at Compass Point from $18.00 to $19.00 in a research report issued on Wednesday, Benzinga reports. The firm presently... More of this article »
Image about DoubleVerify (NYSE:DV) PT Lowered to $40.00

DoubleVerify (NYSE:DV) PT Lowered to $40.00

DoubleVerify (NYSE:DV – Get Free Report) had its target price dropped by investment analysts at Royal Bank of Canada from $49.00 to $40.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently... More of this article »
Image about Alphatec (NASDAQ:ATEC) Announces  Earnings Results, Misses Estimates By $0.01 EPS

Alphatec (NASDAQ:ATEC) Announces Earnings Results, Misses Estimates By $0.01 EPS

Alphatec (NASDAQ:ATEC – Get Free Report) issued its quarterly earnings data on Tuesday. The medical technology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.01), Briefing.com reports.... More of this article »
Image about eGain (NASDAQ:EGAN) Updates Q4 2024 Earnings Guidance

eGain (NASDAQ:EGAN) Updates Q4 2024 Earnings Guidance

eGain (NASDAQ:EGAN – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.010-0.030 for the period, compared to the consensus... More of this article »
Image about eGain (NASDAQ:EGAN) Issues FY 2024 Earnings Guidance

eGain (NASDAQ:EGAN) Issues FY 2024 Earnings Guidance

eGain (NASDAQ:EGAN – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.320-0.340 for the period, compared to the consensus earnings per... More of this article »
Image about Cambium Networks (NASDAQ:CMBM) Updates Q2 2024 Earnings Guidance

Cambium Networks (NASDAQ:CMBM) Updates Q2 2024 Earnings Guidance

Cambium Networks (NASDAQ:CMBM – Get Free Report) updated its second quarter 2024 earnings guidance on Thursday. The company provided earnings per share guidance of -0.240–0.190 for the period, compared to the consensus... More of this article »
Image about Cambium Networks (NASDAQ:CMBM) Updates FY 2024 Earnings Guidance

Cambium Networks (NASDAQ:CMBM) Updates FY 2024 Earnings Guidance

Cambium Networks (NASDAQ:CMBM – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of -0.640–0.410 for the period, compared to the consensus... More of this article »
Image about FibroGen, Inc. (NASDAQ:FGEN) to Post Q2 2024 Earnings of ($0.24) Per Share, William Blair Forecasts

FibroGen, Inc. (NASDAQ:FGEN) to Post Q2 2024 Earnings of ($0.24) Per Share, William Blair Forecasts

FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities researchers at William Blair increased their Q2 2024 earnings estimates for shares of FibroGen in a research note issued on Tuesday, May 7th. William Blair analyst... More of this article »
Image about Q2 2024 EPS Estimates for Dine Brands Global, Inc. (NYSE:DIN) Reduced by Analyst

Q2 2024 EPS Estimates for Dine Brands Global, Inc. (NYSE:DIN) Reduced by Analyst

Dine Brands Global, Inc. (NYSE:DIN – Free Report) – Analysts at Wedbush lowered their Q2 2024 earnings estimates for Dine Brands Global in a report released on Thursday, May 9th. Wedbush analyst N. Setyan now expects... More of this article »
Image about William Blair Analysts Cut Earnings Estimates for Elanco Animal Health Incorporated (NYSE:ELAN)

William Blair Analysts Cut Earnings Estimates for Elanco Animal Health Incorporated (NYSE:ELAN)

Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) – William Blair lowered their Q2 2024 earnings per share (EPS) estimates for Elanco Animal Health in a research report issued on Wednesday, May 8th. William... More of this article »
Image about Spire Wealth Management Grows Stock Holdings in Canadian National Railway (NYSE:CNI)

Spire Wealth Management Grows Stock Holdings in Canadian National Railway (NYSE:CNI)

Spire Wealth Management boosted its stake in shares of Canadian National Railway (NYSE:CNI – Free Report) (TSE:CNR) by 7.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange... More of this article »
Image about Spire Wealth Management Purchases 90,811 Shares of Peloton Interactive, Inc. (NASDAQ:PTON)

Spire Wealth Management Purchases 90,811 Shares of Peloton Interactive, Inc. (NASDAQ:PTON)

Spire Wealth Management grew its position in shares of Peloton Interactive, Inc. (NASDAQ:PTON – Free Report) by 421.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange... More of this article »
Image about Spire Wealth Management Has $628,000 Stock Holdings in Capital Group International Focus Equity ETF (NYSEARCA:CGXU)

Spire Wealth Management Has $628,000 Stock Holdings in Capital Group International Focus Equity ETF (NYSEARCA:CGXU)

Spire Wealth Management boosted its holdings in Capital Group International Focus Equity ETF (NYSEARCA:CGXU – Free Report) by 49.0% in the fourth quarter, HoldingsChannel reports. The firm owned 26,562 shares of the company’s... More of this article »
Image about Spire Wealth Management Lowers Position in ONEOK, Inc. (NYSE:OKE)

Spire Wealth Management Lowers Position in ONEOK, Inc. (NYSE:OKE)

Spire Wealth Management reduced its stake in ONEOK, Inc. (NYSE:OKE – Free Report) by 25.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 9,067 shares of the utilities... More of this article »
Image about Spire Wealth Management Has $641,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Spire Wealth Management Has $641,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Spire Wealth Management trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 15.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The... More of this article »